Danish drugmaker Genmab has upped its relationship with long-term CDMO partner Lonza by reserving space at the Ibex Design and Ibex Develop facilities in Switzerland. Contract development and manufacturing organization (CDMO) is constructing a biopark at its site and headquarters in Visp, Switzerland, to support its range of Ibex biologics development and manufacturing services. Denmark’s Genmab has been working with Lonza on multiple antibody-based programs since 2002, and with its strategy to fully outsource its biomanufacturing, the firm has reserved…